RIKEN Kobe Institute - Center for Developmental Biology
Research institute focusing on regeneration and basic studies with regard to medical applications
RIKEN is an independent administrative institution under the Ministry of Education, Culture, Sports, Science and Technology of Japan. RIKEN established the Center for Developmental Biology (CDB) in April 2000. CDB is situated in Kobe and has 31 different laboratories in the field of developmental biology including embryology, developmental cell biology, neural developmental biology, stem cell and tissue regeneration research and evolutional biology.
Ryoji Noyori, President of RIKEN
Masatoshi Takeichi, PhD, Director of Center for CDB
Takashi Murata, Deputy Director
2-2-3 Minatojima-minamimachi,
Chuo-ku Kobe 650-0047
Japan
Phone: +81-78-306-0111
Fax: +81-78-306-0101
Core programmes involve stem cell biology, cell adhesion and tissue patterning, evolutionary regeneration biology, vertebrate body plan, organogenesis and neurogenesis, morphogenetic signaling and cell asymmetry. The Laboratory for Stem Cell Research under the leadership of Dr. Shin-Ichi Nishikawa focuses on stem cells and the regulation mechanisms underlying mesoderm specification.
The Laboratory for Evolutionary Regeneration Biology is led by Dr. Kiyokazu Agata and investigates the molecular basis of totipotent stem cells, the molecular basis of the stem cell system and its evolutionary developmental biology.
The Laboratory for Stem Cell Translational Research is directed by Dr. Takayuki Asahara, who investigates the isolation of post-natal pluripotent stem cells, the cellular and molecular determination of pluripotent stem cell differentiation and the significance of vascular development in organogenesis.
The Research Unit for Organ Regeneration under the leadership of Dr. Hideki Taniguchi is focused on the identification and characterisation of somatic stem cells in solid organs as well as on the development of stem cell therapy for organ failures.
The following section contains a selection of the company’s most relevant patents. For comprehensive patent information please refer to the espacenet databases.